receives request for additional information

Thoratec (THOR) and HeartWare (HTWR) Receives Request for Additional Information From FTC Regarding Merger

More News related to HTWR

* Thoratec (THOR) and HeartWare (HTWR) Receives Request for Additional Information From FTC Regarding Merger
* Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission

More News related to HTWR
More News related to THOR

* Thoratec (THOR) and HeartWare (HTWR) Receives Request for Additional Information From FTC Regarding Merger
* Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission
* Quarterly Changes to the NASDAQ Q-50 Index
* Thoratec Presentation at Raymond James Conference to Be Webcast
* Piper Jaffray Upgrades Thoratec (THOR) to Buy; Pullback Provides Attractive Entry Point

More News related to THOR
Click here to find out more!
More News related to Mergers and Acquisitions

* Thoratec (THOR) and HeartWare (HTWR) Receives Request for Additional Information From FTC Regarding Merger
* Shenandoah Telecommunications (SHEN) Announces Plan to Buy North River Telephone Cooperative
* IBM's (IBM) Talks with Sun Micro (JAVA) Continue
* Will Ramco-Gershenson (RPT) Be Taken Out?
* Roche Completes Acquisition of Genentech (DNA)

More News related to Mergers and Acquisitions
March 26, 2009 4:38 PM EDT

Thoratec Corporation (Nasdaq: THOR) and HeartWare International, Inc. (Nasdaq: HTWR) announced today that they each received a Request for Additional Information, or a "second request," from the United States Federal Trade Commission ("FTC") in connection with the FTC's review of Thoratec's proposed acquisition of HeartWare International under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "Act"). This second request from the FTC is a standard part of the full regulatory process.

The transaction, which was announced on February 13, 2009, is subject to approval of HeartWare's stockholders and satisfaction of other customary closing conditions, including expiration or termination of the waiting period under the Act. The effect of the second request is to extend the waiting period imposed by the Act until thirty days after Thoratec and HeartWare have substantially complied with the second request, unless that period is extended voluntarily by the parties or terminated sooner by the FTC. The companies are gathering information to respond promptly to the second request and are cooperating fully with the FTC in connection with its review. Both companies expect the transaction to close in the second half of 2009.[SM]